Use of a composition comprising a polypeptide of Interleukin 18 (il-18) in combination with a vehicle and a monoclonal antibody against an Antigen that is expressed on the surface of a cellA cancer that is not an anti-cd20 Antibody pair

摘要

The present invention relates generally to the use of human IL-18 combinations in the treatment of various forms of solid tumors and lymphomas. In particular, the present invention relates to combinations of human IL-18 with chemotherapeutc agents, specifically pazopanib.